Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$0.97
2014 $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Would you rather buy gold @ $2200 and wait 2 years for $3000
or Elite@$0.13 and wait 2 years for Dollar land ?
Maybe mostly for secure storage at first ?
Someone gave me a bag of cheeseburgers the small ones.
They were god awe-full . Years ago they would melt in your mouth with a soft bun.
These the buns were burnt some how, unless they started toasting ?
I got one down very chewy buns. I threw the rest away.
Maybe it was bad luck or new cook ? Stale bread?
GLTA
Shorts burn when next pr drops.
I put a rush on my funds.
I’m also putting some lots up for sale which may take awhile.
I sell myself without realtor so I can buy more Elite.
I’m adding 250,000 more Monday or Tuesday
22 months to accumulate
GLTA
We are gonna need a bigger truck to go along with the new facility !
8600 Walgreens pharmacies to stock up with Adderall.
Elite's Monster Unique second generation IR ADF is 90% cheaper to produce (drug C below) compared to ADFs containing Naltrexone. It can also be used with CNS stimulants to make them abuse deterrent.
The holy grail of IR ADFs trials resume in 2022
Making others obsolete.
Hammer locking the IR ADF market in 2024:
Generic ADT OxyContin is on track to be filed between January 1, 2023 - March 31, 2023. Send us straight to DollarLand !
Patent Pending
Quote Nasrat:
I think you’re right. Here is his first post. It was about Elite’s secret undisclosed Unique ADF that ran right beside SequestOx. Item #23 on Catalyst list
In ensuing CC he said they were applying for a patent for it. Then they went quiet.
This could reappear any time. It is 90% cheaper to produce than the reformulated SeQuestox.
I cant ever seem to get enough, lol
We also have Wine chemist another pharmacist .
Add ‘em up:
Coming ELTP Catalyst :
X 1. Cash Flow Positive Status - 4 + years
X 2. Purchase building which houses their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirkov, Doug and the Team
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023 First to File Aug 17, 2023
__12. Generate revenues over $20 million/quarter
__13. Generic OxyContin Approval - $720 Million IMS market
__14. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
X 15. Lease additional manufacturing and storage space for new ANDAs Jan 2024 - 34,000 square foot 18+ ft ceilings
__16. European distribution Dexcel partnership approval by Israeli Health
__17. Full ownership of Adderall IR $ 335 Million
__18. Full ownership of Adderall XR $ 1.56 Billion
__19. Generic Concerta- $1.2 BILLION FDA submission
__20. Vigabatrin - VigPoder approved Pyros $233 Million trade mark challenge
__21. $100 million in yearly revenues
__22. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
__23. Patented Unique ADF (w/o naltrexone)-- NDA
__24. Mikah ANDA (s)
__25. Undisclosed ANDAs/NDAs
__26. Antimetabolite ANDA- Methotrexate $ 600 Million
__27. Undisclosed Antimetabolite ANDA- $42 Million
__28. Generic Vyvanse Approval
__29. DollarLand PPS
__30. Uplist to the NASDAQ Exchange
__31. THE Buy Out ! 2.0-2.5 yrs from Feb 2024
__32. Vegas Baby !!!!!!! 2.5 yrs
X 33. PE under 8
BULLISH
PE less than 8
Combined $10 Billion IMS markets
The Gem of the OTC
Are ya talking about Big Daddy Mac ?
If so you never know ?
Can ya wait another 22 months ?
Are ya saying your selling Before DollarLand ??
Generic OxyContin $720 million
Vyvance $5.1 Billion
Concerta $1.2 Billion
Addrerall IR $335 million
Adderall XR $1.6 Billion
vigbatin $336 million
There ya go again.
Hang in there.
I randomly picked one:
bubba412
Re: NASDAQ2020 post# 391878
Monday, December 04, 2023 2:03:47 PM
Post#
391880
of 398683
You forgot 2 key negatives in your list of positives A billion shares issued Mikah secrecy deals Jusy sayin
How is it you ended up at the top of the basher list ?
My 9 trading accounts say otherwise, LOL
It your an actual share holder why have you disliked the co. for the last 10 yrs
More funds coming Monday or TUESDAY.
This looks like the next HammerBottom since 2 cents.
do something nice for yourself or family
STAIR STEPPING up from 2 cents. Its the usual pull back after a 600% gain over a few months. Between now and next CC it will reverse again for the next leg up 21-38
Heres why:
Up Coming ELTP Catalyst :
X 1. Cash Flow Positive Status - 4 + years
X 2. Purchase building which houses their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirkov, Doug and the Team
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023 First to File Aug 17, 2023
__12. Generate revenues over $20 million/quarter
__13. Generic OxyContin Approval - $720 Million IMS market
__14. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
X 15. Lease additional manufacturing and storage space for new ANDAs Jan 2024 - 34,000 square foot 18+ ft ceilings
__16. European distribution Dexcel partnership approval by Israeli Health
__17. Full ownership of Adderall IR $ 335 Million
__18. Full ownership of Adderall XR $ 1.56 Billion
__19. Generic Concerta- $1.2 BILLION FDA submission
__20. Vigabatrin - VigPoder approved Pyros $233 Million trade mark challenge
__21. $100 million in yearly revenues
__22. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
__23. Patented Unique ADF (w/o naltrexone)-- NDA
__24. Mikah ANDA (s)
__25. Undisclosed ANDAs/NDAs
__26. Antimetabolite ANDA- Methotrexate -$600 Million
__27. Undisclosed Antimetabolite ANDA- $42 Million
__28. Generic Vyvanse Approval
__29. DollarLand PPS
__30. Uplist to the NASDAQ Exchange
__31. THE Buy Out ! 2.0-2.5 yrs from Feb 2024
__32. Vegas Baby !!!!!!! 2.5 yrs
X 33. PE under 8
BULLISH
PE less than 8
Combined $10 Billion IMS markets
IVE SEEN 50 MILLION SHARES TRADED IN A DAY WITHE ELITE IN 2014
$$$$$$$$$$$$$$$$$$$$$
Shortages:
FDA shortage link
for Adderall:
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1
FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c
FDA shortage link for Naltrexone
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c
Bullish
Up Coming ELTP Catalyst :
X 1. Cash Flow Positive Status - 4 + years
X 2. Purchase building which houses their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirkov, Doug and the Team
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023 First to File Aug 17, 2023
__12. Generate revenues over $20 million/quarter
__13. Generic OxyContin Approval - $720 Million IMS market
__14. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
X 15. Lease additional manufacturing and storage space for new ANDAs Jan 2024 - 34,000 square foot 18+ ft ceilings
__16. European distribution Dexcel partnership approval by Israeli Health
__17. Full ownership of Adderall IR $ 335 Million
__18. Full ownership of Adderall XR $ 1.56 Billion
__19. Generic Concerta- $1.2 BILLION FDA submission
__20. Vigabatrin - VigPoder approved Pyros $233 Million trade mark challenge
__21. $100 million in yearly revenues
__22. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
__23. Patented Unique ADF (w/o naltrexone)-- NDA
__24. Mikah ANDA (s)
__25. Undisclosed ANDAs/NDAs
__26. Antimetabolite ANDA- Methotrexate -$600 Million
__27. Undisclosed Antimetabolite ANDA- $42 Million
__28. Generic Vyvanse Approval
__29. DollarLand PPS
__30. Uplist to the NASDAQ Exchange
__31. THE Buy Out ! 2.0-2.5 yrs from Feb 2024
__32. Vegas Baby !!!!!!! 2.5 yrs
X 33. PE under 8
BULLISH
Elite Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with Veeda Clinical Research Ltd for methotrexate (GDCT0466264)
I dont think thats the one do you see Elites name in the link ??
There was a link that showed an association with Elite.
Someone with Ihub membership can do a search, to see if it’s worth keeping it on there.
ANYONE HAVE A LINK TO THIS DRUG and Elite Pharma ??
__26. Antimetabolite ANDA- Methotrexate -$600 Million
It was not from Elite someone found an association with the two on line a year or two ago.
Without an I-hub memebership I cant find it easily. Probaly from around JAN 2023
Any other co. would not sell us the other 1/2 of Adderall back where it belongs.
Have no definitive plans right now.
Do I need to have funds ready ??
I never got around to getting funds for this week
Thur or Fri is the fastest I can do.
Best quarter in co.s history.
Droopy Dog view of the world
Dotting the I's and crossing the T's
Shortages:
FDA shortage link
for Adderall:
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1
FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c
FDA shortage link for Naltrexone
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c
Bullish
HAMMER TIME !
X 1. Cash Flow Positive Status - 4 + years
X 2. Purchase building which houses their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirkov, Doug and the Team
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023 First to File Aug 17, 2023
__12. Generate revenues over $20 million/quarter
__13. Generic OxyContin Approval - $720 Million IMS market
__14. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
X 15. Lease additional manufacturing and storage space for new ANDAs Jan 2024 - 34,000 square foot 18+ ft ceilings
__16. European distribution Dexcel partnership approval by Israeli Health
__17. Full ownership of Adderall IR $ 335 Million
__18. Full ownership of Adderall XR $ 1.56 Billion
__19. Generic Concerta- $1.2 BILLION FDA submission
__20. Vigabatrin - VigPoder approved Pyros $233 Million trade mark challenge
__21. $100 million in yearly revenues
__22. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
__23. Patented Unique ADF (w/o naltrexone)-- NDA
__24. Mikah ANDA (s)
__25. Undisclosed ANDAs/NDAs
__26. Antimetabolite ANDA- Methotrexate -$600 Million
__27. Undisclosed Antimetabolite ANDA- $42 Million
__28. Generic Vyvanse Approval
__29. DollarLand PPS
__30. Uplist to the NASDAQ Exchange
__31. THE Buy Out ! 2.0-2.5 yrs from Feb 2024
__32. Vegas Baby !!!!!!! 2.5 yrs
X 33. PE under 8
More funds coming next week.
$$$$$$$$$$$$$$
ELTP
Ive increased my share count 25% in past year. Im sitting in the CatBird seat .
ELTP
How many Billion$ for ButOut
Your best caluculation?
$1
$2
$3
$4
$5